UK markets closed

Accelerate Diagnostics, Inc. (0H8E.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.9245+0.0640 (+7.44%)
At close: 05:44PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.53
52-week change 3128.34%
S&P500 52-week change 322.38%
52-week high 37.0822
52-week low 30.0000
50-day moving average 33.1528
200-day moving average 32.9229

Share statistics

Avg vol (3-month) 3995
Avg vol (10-day) 3416
Shares outstanding 554.15M
Implied shares outstanding 6N/A
Float 813.46M
% held by insiders 137.11%
% held by institutions 112.85%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.1:1
Last split date 312 Jul 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-354.48%

Management effectiveness

Return on assets (ttm)-70.07%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)12.06M
Revenue per share (ttm)0.97
Quarterly revenue growth (yoy)1.90%
Gross profit (ttm)N/A
EBITDA -50.77M
Net income avi to common (ttm)-61.62M
Diluted EPS (ttm)-1.0560
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.22M
Total cash per share (mrq)0.61
Total debt (mrq)39.22M
Total debt/equity (mrq)N/A
Current ratio (mrq)2.03
Book value per share (mrq)-1.37

Cash flow statement

Operating cash flow (ttm)-40.2M
Levered free cash flow (ttm)-25.94M